Impact of inherited bleeding disorders on pregnancy and postpartum hemorrhage
- 1 October 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 23 (7) , 603-607
Abstract
Inherited bleeding disorders are caused by various genetic defects in the proteins involved in haemostasis. Female patients or carriers are faced with the risk of haemorrhage throughout life. During pregnancy and postpartum, this complication affects the health of either the mother or the baby, or both. This retrospective cohort study was designed to assess the occurrence of obstetric bleeding in the three trimesters of pregnancy, along with primary and secondary postpartum haemorrhage among 100 women with inherited bleeding disorders. A questionnaire was designed in order to collect historical data. The patients were evaluated in three groups: haemophilia carriers, von Willebrand disease (VWD) and rare bleeding disorders. In comparison with normal women, significantly severe bleeding was observed among patients in all of the five stages. VWD patients showed a higher frequency of bleeding in first trimester but the rate of miscarriage was lower. Haemophilia carriers were threatened with bleeding complications during the prenatal period, but they also had the highest frequency of postpartum haemorrhage. Based on our results, vaginal bleeding is a serious threat in all three patient groups, especially during the first trimester of pregnancy and in the postpartum period.Keywords
This publication has 31 references indexed in Scilit:
- Management of pregnancy and delivery in women with inherited bleeding disordersSeminars in Fetal and Neonatal Medicine, 2011
- Management of pregnancy, labour and delivery in women with inherited bleeding disordersHaemophilia, 2011
- A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD)Journal of Thrombosis and Haemostasis, 2006
- Haemostatic changes in pregnancyBest Practice & Research Clinical Haematology, 2003
- Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancyAnnals of Hematology, 2002
- Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal andheparin-treated antiphospholipid syndrome pregnanciesLupus, 2002
- Iron deficiency anemia increases nitric oxide production in healthy adolescentsAnnals of Hematology, 2001
- Coagulation factor XIII in pregnant smokers and non-smokersInternational Journal of Clinical and Laboratory Research, 1997
- Studies on Blood Coagulation and Fibrinolysis in Pregnancy, during Delivery and in the PuerperiumGynecologic and Obstetric Investigation, 1981
- Changes in factor XI (plasma thromboplastin antecedent) levels during pregnancyAmerican Journal of Obstetrics and Gynecology, 1973